mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |